Drugs / PF-03716539
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00783484 | Oct 2008 → May 2009 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-03716539 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00783484 ↗ |
| Route | Oral | “PF-03716539 10 mg oral solution, single dose” NCT00783484 ↗ |